Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
    Review

    Costa, F.; Wiedenmann, B.; Roderburg, C.; Mohr, R.; Abou-Alfa, G. K.
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas
    Journal Article

    Raj, N.; Chan, J. A.; Wang, S. J.; Aggarwal, R. R.; Calabrese, S.; DeMore, A.; Fong, L.; Grabowsky, J.; Hope, T. A.; Kolli, K. P.; more...
    British Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: Findings from CALGB/SWOG 80702 (Alliance)
    Journal Article

    Lee, S.; Ma, C.; Shi, Q.; Meyers, J.; Kumar, P.; Couture, F.; Kuebler, P.; Krishnamurthi, S.; Lewis, D.; Tan, B.; more...
    British Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): A multicentre, single-arm, phase 2b study
    Journal Article

    Harding, J. J.; Fan, J.; Oh, D. Y.; Choi, H. J.; Kim, J. W.; Chang, H. M.; Bao, L.; Sun, H. C.; Macarulla, T.; Xie, F.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): Primary and updated analyses from a single-arm, phase 2 study
    Journal Article

    Van Cutsem, E.; di Bartolomeo, M.; Smyth, E.; Chau, I.; Park, H.; Siena, S.; Lonardi, S.; Wainberg, Z. A.; Ajani, J.; Chao, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Registration-based biomarkers for neoadjuvant treatment response of pancreatic cancer via longitudinal image registration
    Journal Article

    Heiselman, J. S.; Ecker, B. L.; Langdon-Embry, L.; O'Reilly, E. M.; Miga, M. I.; Jarnagin, W. R.; Do, R. K. G.; Horvat, N.; Wei, A. C.; Chakraborty, J.
    Journal of Medical Imaging (2023)

    Fulltext@MSK | Save
  • Reply to M.C. Strach et al
    Correspondence

    Foote, M. B.; Nash, G. M.; Cercek, A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Flashback foreword: Bevacizumab and FOLFOX4 for colorectal cancer and bevacizumab versus placebo plus oxaliplatin-based chemotherapy in metastatic colorectal cancer
    Editorial

    O'Reilly, E. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study
    Journal Article

    Saltz, L. B.; Clarke, S.; Díaz-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; Koski, S.; Lichinitser, M.; Yang, T. S.; Rivera, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Anal carcinoma, version 2.2023: NCCN Clinical Practice Guidelines in Oncology
    Guidelines

    Benson, A. B. 3rd; Venook, A. P.; Al-Hawary, M. M.; Azad, N.; Chen, Y. J.; Ciombor, K. K.; Cohen, S.; Cooper, H. S.; Deming, D.; Garrido-Laguna, I.; more...
    Journal of the National Comprehensive Cancer Network (2023)

    Fulltext@MSK | Save